TY  - CHAP
AU  - Hitomi Fujie
AU  - Muneo Numasaki
ED  - Hilal Arnouk
Y1  - 2012-02-03
PY  - 2012
T1  - Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy
N2  - Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.
BT  - Advancements in Tumor Immunotherapy and Cancer Vaccines
SP  - Ch. 9
UR  - https://doi.org/10.5772/28436
DO  - 10.5772/28436
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-24
ER  -